Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor α production in trinitrobenzene sulphonic acid induced colitis

Gut

Volumn 41, Issue 4, 1997, Pages 487-493

  Ameho, C K ^a   Adjei, A A ^a   Harrison, E K ^a   Takeshita, K ^a   Morioka, T ^a   Arakaki, Y ^a   Ito, E ^a   Suzuki, I ^d   Kulkarni, A D ^b   Kawajiri, A ^c   Yamamoto, S ^e  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b St Louis Medical Center   (United States)

^c Daidochuo Hospital   (Japan)

^d PREFECTURAL UNIVERSITY OF KUMAMOTO   (Japan)

^e UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Glutamine; Inflammatory bowel disease; Interleukin 8; Rats; Trinitrobenzene sulphonic acid; Tumour necrosis factor

Indexed keywords

GLUTAMINE; INTERLEUKIN 8; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; COLITIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; INFLAMMATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 9844228499     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.4.487     Document Type: Article

References (51)

1. Olson CO, Sartor RB, Tennyson GS, Ridell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109: 1344-67.
2. Seidman E, Leleiko N, Ament M, Berman W, Caplan D, Evans J, et al. Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991; 12: 424-8.
3. Levi AJ. Diet in the management of Crohn's Disease, Gut 1985; 26: 985-8.
4. O'Morian C. Diet and Crohn disease. Mol Aspects Med 1987; 9: 113-8.
5. Seidman EG, Roy CC, Weber AM, Morin CL. Nutritional therapy of Crohn's disease in childhood. Dig Dis Sci; 1087; 32: 82S-8S.
6. Seidman E, Sabbah S, Atlan P, Grey VL, Morin CL. Elemental diet in inflammatory bowel disease. Can J Gas- toenterol 1988; 26A-34A.
7. Windmueller HG, Spaeth AH. Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem 1980; 249: 5070-9.
8. Souba WW, Klimberg VS, Plumley DA, Salloum RM, Flynn TC, Bland KI, Copeland III EM. The role of glutamine in maintaining the gut and supporting the metabolic response to injury and infection. J Surg Res 1990; 48: 383-91.
9. Roediger WEW. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 1982; 83: 424-9.
10. Souba WW, Smith RJ, Wilmore DW. Glutamine metabolism in the intestinal tract. Journal of Parenteral and Enteral Nutrition 1985; 9: 608-17.
11. Fox AD, Kripke SA, Berman JM, Settle RG, Rombeau JL. The effect of glutamine supplemented enteral nutrition on methotrexate induced enterocolitis (abstract). Am J Clin Nutr 1987; 45: 850.
12. Jacobs DO, Evans DA, O'Dwyer ST, Smith RJ, Wilmore DW. Disparate effect of fluorouracil on the ileum and colon of enterally fed rats with protection by dietary glutamine. Surg Forum 1987; 38: 45-9.
13. Fox AD, Kripke SA, De Paula J, Berman JM, Settle RG, Rombeau JL. Effect of glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. Journal of Parenteral and Enteral Nutrition 1988; 12: 325-31.
14. Fujita T, Sakurai K. Efficacy of glutamine-enriched enteral nutrition in an experimental model of ulcerative colitis. Br J Surg 1995; 82: 749-51.
15. Barber AE, Jones WG, Minei JP, Fahey III TJ, Moldawer LL, Rayburn JL, et al. Glutamine or fiber supplementation of a defined fomula diet: impact on bacterial translocation, tissue composition, and response to endotoxin. Journal of Parenteral and Enteral Nutrition 1990; 14: 335-43.
16. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Oppenheim JJ, Leonard EJ. Purification of a human monocytes-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defence cytokines. Proc Natl Acad Sci USA 1987; 84: 9233-7.
17. Schroder J-M , Morowietz E, Morita E. Purification and partial biochemical characterization of a human monocytederived neutrophil activating peptide that lacks interleukin 1 activity. J Immunol 1987; 139: 3474-83.
18. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988; 167: 1883-93.
19. 4 synthesis. J Invest Dermatol 1991; 96: 690-4.
20. Leonard EJ, Yoshimura T, Tanaka S, Raffeld M. Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. J Invest Dermatol 1991; 96: 260-6.
21. Thelen M, Peveri P, Kernen P, Von Tscharner V, Baggiolini M. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 1988; 2: 2702-6.
22. Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tataeishi A, Nishiyama T, et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1994; 96: 432-6.
23. Mahida YR, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey CJ. Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci 1992; 82: 273-5.
24. Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989; 96: 29-30.
25. Higa A, Mcknight GW, Wallace JL. Attenuation of epithelial injury in acute experimental colitis by immunomodulators. Eur T Pharmacol 1993; 239: 171-6.
26. Rolandelli RH, Saul SH, Settle RG, Jacobs DO, Trerotola SO, Rombeau JL. Comparison of parenteral nutrition and enteral feeding with pectin in experimental colitis in the rat. Am J Clin Nutr 1988; 47: 715-21.
27. Macpherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion 1978; 17: 35-50.
28. Apteker L, Goldin E, Wengrower D, Okon E. Beneficial effects of glutamine in TNB-induced experimental colitis [abstract]. Gastroenterology 1996; 110: A852.
29. Klimberg VS, Souba WW, Dolson DJ, Salloum RM, Hautamaki RD, Plumley DA, et al. Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer 1990; 66: 62-6.
30. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
31. Allgayer H, Deschryver K, Stenson WF. Treatment with 16,16′-dimethyl-prostaglandin E2 before and after indue- tion of colitis with trinitrobenzene sulphonic acid in rats decreases inflammation. Gasstroenterology 1980; 96: 1200-300.
32. Rachmilewitz D, Simon PL, Schwartz LW, Griswold DE, Fondacaro JD, Wasserman MA. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1980; 97: 326-37.
33. Vialseca J, Salas A, Guarner F, Rodriguez R, Malagelada JR. Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis. Gastroenterology 1990; 98: 267-77.
34. Wallace JL, Keenen CM, Gale D, Shoupe, TS. Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B, synthesis. Gastroenterology 1902; 102: 18-27.
35. Pons L, Droy-Lefaix MT, Bueno L. Leukotriene D participates in colonic transit disturbances induced by intracolonic administration of trinitrobenzene sulphonic acid in rats. Gastroenterology 1992; 102: 149-56.
36. Ford Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes, Nature 1080; 286: 264-5.
37. Lee T-C, Synder F. Function, metabolism and regulation of platelet-activating factor and related ether lipids. In: Kuo JF, ed. Phospholipids and cellular regulation. Vol. 2. Boca Raton: CRC Press, 1985: 1.
38. Fernandez NH, Henson PM, Otani A, Hugh TE. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vitro conditions. J Immunol 1978; 120: 109-15.
39. Falk W, Leonard EJ. Human monocyte chemotaxis: migrating cells are a subpopulation of with multiple chemotaxin specificities on each cell. Infect Immun 1980; 29: 953-9.
40. Suzuki I, Matsumoto Y, Adjei AA, Asato S, Shinjo S, Yamamoto S. Effect of glutamine-supplemented diet on response to methicillin-resisitant Staphylococcus aureus infection in mice. J Nutr Sci Vitaminol 1993; 39: 405-10.
41. Fiocchi C. Cytokines and intestinal inflammation. Transplam Proc 1906; 28: 2442-3.
42. Burke DJ, Alverdy JC, Aoys F, Moss GS. Glutamine-supplemented total parenteral nutrition improves gut immune function. Arch Surg 1980; 124: 1306-9.
43. Bergman KC, Waldman KC. Stimulation of secretory antibody following oral administration of antigen. Rev Infect Dis 1988; 10: 939-50.
44. Onderdonk AB, Hermos JA, Dzink JL, Bartlett JG. Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology 1978; 74: 521-6.
45. Onderdonk AB, Bartlett JG. Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr 1979; 32: 258-65.
46. Ohkusa T, Yamada M, Takenaga T, Kitazuma C, Yamamoto M, Sasabe M, et al. Protective effect of metronidazole in experimental ulcerative colitis induced by dextran sulphate sodium. Jpn J Gastroenterol 1987; 84: 2337-46.
47. Windmueller HG. Glutamine utilization by the small intestine. Adv Enzymol 1982; 53: 202-37.
48. Souba WW. Glutamine metabolism in catabolic states. Role of the intestinal tract (thesis). Harvard School of Public Health, Department of Nutritional Biochemistry, June 1984.
49. Higashiguchi T, Hasselgren PO, Wagner K, Fischer JE. Effect of glutamine on protein synthesis in isolated intestinal epithelial cells. Journal of Parenteral and Enteral Nutrition 1093; 17: 307-14.
50. Adjei AA, Morioka T, Ameho CK, Yamauchi K, Kulkarni AD, Al-Mansouri HMSH, et al. Nucleotide-nucleoside mixture free diet protects rat colonic mucosa from damage induced by trinitrobenzene sulphonic acid. Gut 1906; 39: 428-33.
51. Beagley KW, Black CA, Elson CO. Strain differences in susceptibility to TNBS-induced colitis [abstract]. Gastroenter- ology 1991; 100: A560.